483 Joel D. Cooper, M.D. Sep 2017

483 Joel D. Cooper, M.D. Sep 2017

Marcelo Mangalindan FDA$119.00 - Available Now

FDA investigators audited the Joel D. Cooper, M.D. - Philadelphia, PA, United States facility and issued inspectional observations (via FDA 483) on 27 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Sep 2017
  • Location: Philadelphia, United States
  • FEI: 3005921257
Add To Cart